OncoTherapy Science, Inc. (4564) Other
Market cap
¥8B
P/E ratio
OncoTherapy Science develops cancer treatments using genetic research, including targeted drugs, immunotherapies, and precision medicine testing for personalized cancer care.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | -4.4 | -6.6 | -7.6 | -15.5 | -8.8 | -9 | -14.3 | -9.8 | -25.3 | -9.7 | -7.2 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 87 | 85 | 76 | 55 | 55 | 54 | 56 | 63 | 62 | 66 | 67 | 60 | 54 | 47 | 46 |